Serum aminotransferase activity and mortality risk in a United States community

Hepatology

Volumn 47, Issue 3, 2008, Pages 880-887

  Tae, Hoon Lee ^a   Kim, W Ray ^a,b   Benson, Joanne T ^b   Therneau, Terry M ^b   Melton III, L Joseph ^b  

^a MAYO CLINIC   (United States)

^b Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD CHEMISTRY; CAUCASIAN; COMMUNITY; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HEALTH SURVEY; HUMAN; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PATIENT SELECTION; PRIORITY JOURNAL; STATISTICAL PARAMETERS; STATISTICAL SIGNIFICANCE; SURVIVAL; UNITED STATES; AGED; BLOOD; MIDDLE AGED;

ADULT; AGED; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; FEMALE; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED; MINNESOTA; SURVIVAL ANALYSIS;

EID: 40949103928     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22090     Document Type: Article

References (31)

1. Wroblewski F, Ladue JS. Serum glutamic pyruvic transaminase in cardiac with hepatic disease. Proc Soc Exp Biol Med 1956;91:569-571.
2. Wroblewski F, Ladue JS. Serum glutamic oxalacetic aminopherase (transaminase) in hepatitis. J Am Med Assoc 1956;160:1130-1134.
3. Wroblewski F. The clinical significance of transaminase activities of serum. Am J Med 1959;27:911-923.
4. Arndt V, Brenner H, Rothenbacher D, Zschenderlein B, Fraisse E, Fliedner TM. Elevated liver enzyme activity in construction workers: prevalence and impact on early retirement and all-cause mortality. Int Arch Occup Environ Health 1998;71:405-412.
5. Kim HC, Nam CM, Jee SH, Han KH, Oh DK, Suh I. Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study. BMJ 2004;328:983.
6. Ioannou GN, Boyko EJ, Lee SP. The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002. Am J Gastroenterol 2006;101:76-82.
7. Daniel S, Ben-Menachem T, Vasudevan G, Ma CK, Blumenkehl M. Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients. Am J Gastroenterol 1999; 94:3010-3014.
8. Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999;107:450-455.
9. Ioannou GN, Weiss NS, Boyko EJ, Mozaffarian D, Lee SP. Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States. HEPATOLOGY 2006;43:1145-1151.
10. Melton L. History of the Rochester Epidemiology Project. Mayo Clin Proc 1996;71:266-274.
11. Therneau TM, Offord J. Technical Report Series No. 63, Expected Survival Based on Hazard Rates (update). Department of Health Science Research, Rochester, MN: Mayo Clinic; 1999.
12. Hastie TJ, Tibshirani RJ. Generalized additive models. London: Chapman & Hall, 1990.
13. Venables WN, Ripley BD. Modern applied statistics with S-PLUS. New York: Springer, 1997.
14. Bender R, Zeeb H, Schwarz M, Jockel KH, Berger M. Causes of death in obesity: relevant increase in cardiovascular but not in all-cancer mortality. J Clin Epidemiol 2006;59:1064-1071.
15. Ringbaek T, Seersholm N, Viskum K. Standardised mortality rates in females and males with COPD and asthma. Eur Respir J 2005;25:891-895.
16. Zimmerman HJ, West M. Serum enzyme levels in the diagnosis of hepatic disease. Am J Gastroenterol 1963;40:387-404.
17. Ellis G, Goldberg DM, Spooner RJ, Ward AM. Serum enzyme tests in diseases of the liver and biliary tree. Am J Clin Pathol 1978;70:248-258.
18. Prati D, Taioli E, Zanella A, Della Torre E, Butelli S, Del Vecchio E, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 2002;137:1-10.
19. Piton A, Poynard T, Imbert-Bismut F, Khalil L, Delattre J, Pelissier E, et al. Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. MULTIVIRC Group. HEPATOLOGY 1998;27:1213-1219.
20. Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol. 2003;98: 960-967.
21. Giallourakis CC, Rosenberg PM, Friedman LS. The liver in heart failure. Clin Liver Dis 2002;6:947-967, viii-ix.
22. Reed MB, Wang R, Shillington AM, Clapp JD, Lange JE. The relationship between alcohol use and cigarette smoking in a sample of undergraduate college students. Addict Behav 2007;32:449-464.
23. Sher KJ, Gotham HJ, Erickson DJ, Wood PK. A prospective, high-risk study of the relationship between tobacco dependence and alcohol use disorders. Alcohol Clin Exp Res 1996;20:485-492.
24. Jackson KM, Sher KJ, Wood PK, Bucholz KK. Alcohol and tobacco use disorders in a general population: short-term and long-term associations from the St. Louis epidemiological catchment area study. Drug Alcohol Depend 2003;71:239-253.
25. Williams AF. Alcohol-impaired driving and its consequences in the United States: the past 25 years. J Safety Res 2006;37:123-138.
26. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (EGA) Study. JAMA 1990;264: 2511-2518.
27. Williams I. Epidemiology of hepatitis C in the United States. Am J Med 1999;107:2S-9S.
28. Green RM, Flamm S. AGA technical review on the evaluation of liver chemistry tests. Gastroenterology 2002;123:1367-1384.
29. Kurland LT, Molgaard CA. The patient record in epidemiology. Sci Am 1981;245:54-63.
30. Friedman LS, Dienstag JL, Watkins E, Hinkle CA, Spiers JA, Rieder SV, et al. Evaluation of blood donors with elevated serum alanine aminotransferase levels. Ann Intern Med 1987;107:137-144.
31. USPSTF. The guide to clinical preventive services. Available at: http:// www.ahrq.gov/clinic/pocketgd.htm. Accessed Jan 10, 2007.